Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-13.23%
operating margin TTM
-13.46%
revenue TTM
645.23 Million
revenue per share TTM
11.12$
valuation ratios | |
|---|---|
| pe ratio | -24.54 |
| peg ratio | 0.24 |
| price to book ratio | 2.66 |
| price to sales ratio | 3.30 |
| enterprise value multiple | -181.30 |
| price fair value | 2.66 |
profitability ratios | |
|---|---|
| gross profit margin | 88.07% |
| operating profit margin | -13.46% |
| pretax profit margin | -14.87% |
| net profit margin | -13.23% |
| return on assets | -7.69% |
| return on equity | -10.42% |
| return on capital employed | -10.35% |
liquidity ratios | |
|---|---|
| current ratio | 2.08 |
| quick ratio | 1.84 |
| cash ratio | 0.52 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 309.32 |
| operating cycle | 402.35 |
| days of payables outstanding | 20.61 |
| cash conversion cycle | 381.73 |
| receivables turnover | 3.92 |
| payables turnover | 17.71 |
| inventory turnover | 1.18 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | -48.30 |
| cash flow to debt ratio | 0.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.32 |
| cash per share | 6.41 |
| operating cash flow per share | 0.34 |
| free cash flow operating cash flow ratio | 0.94 |
| cash flow coverage ratios | 0.50 |
| short term coverage ratios | 1.85 |
| capital expenditure coverage ratio | 17.71 |
Frequently Asked Questions
When was the last time Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) reported earnings?
Supernus Pharmaceuticals, Inc. (SUPN) published its most recent earnings results on 03-08-2026.
What is Supernus Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)'s trailing twelve months ROE is -10.42%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Supernus Pharmaceuticals, Inc. (SUPN) currently has a ROA of -7.69%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SUPN's net profit margin stand at?
SUPN reported a profit margin of -13.23% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SUPN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.08 in the most recent quarter. The quick ratio stood at 1.84, with a Debt/Eq ratio of 0.04.